Myseum Financials

MYSE

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Myseum (MYSE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak

1/9

Myseum passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Low Quality

1.04x

For every $1 of reported earnings, Myseum generates $1.04 in operating cash flow (-$4.4M OCF vs -$4.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Revenue

$436

YoY-35.1%

Myseum generated $436 in revenue in fiscal year 2024. This represents a decrease of 35.1% from the prior year.

EBITDA

-$5.3M

YoY+39.9%

Myseum's EBITDA was -$5.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 39.9% from the prior year.

Free Cash Flow

N/A

Net Income

-$4.2M

YoY+49.6%

Myseum reported -$4.2M in net income in fiscal year 2024. This represents an increase of 49.6% from the prior year.

EPS (Diluted)

$-1.43

YoY+65.5%

Myseum earned $-1.43 per diluted share (EPS) in fiscal year 2024. This represents an increase of 65.5% from the prior year.

Cash & Debt

$1.2M

YoY+25.5%

Myseum held $1.2M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

YoY+47.8%

Myseum had 3M shares outstanding in fiscal year 2024. This represents an increase of 47.8% from the prior year.

Gross Margin

N/A

Operating Margin

-1211216.3%

YoY+95931.2pp

Myseum's operating margin was -1211216.3% in fiscal year 2024, reflecting core business profitability. This is up 95931.2 percentage points from the prior year.

Net Margin

-972284.4%

YoY+278455.2pp

Myseum's net profit margin was -972284.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 278455.2 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

$858K

YoY-36.5%

Myseum invested $858K in research and development in fiscal year 2024. This represents a decrease of 36.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

MYSE Income Statement

Metric	FY24	FY23	FY22	FY21	FY20
Revenue	$436-35.1%	$672-98.5%	$46K+939.7%	$4K	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$858K-36.5%	$1.4M+162.4%	$515K	N/A	N/A
SG&A Expenses	$943K+5.6%	$893K-10.0%	$992K+63.2%	$608K+471.6%	$106K
Operating Income	-$5.3M+39.9%	-$8.8M+28.2%	-$12.2M-12.8%	-$10.8M	N/A
Interest Expense	N/A	N/A	N/A	$127-99.7%	$45K
Income Tax	N/A	N/A	N/A	N/A	N/A
Net Income	-$4.2M+49.6%	-$8.4M+30.8%	-$12.1M-12.1%	-$10.8M-1005.6%	-$979K
EPS (Diluted)	$-1.43+65.5%	$-4.14+31.5%	$-6.04-750.7%	$-0.71	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$328+320.5%	$78-6.0%	$83-9.8%	$92+48.4%	$62-58.9%	$151+15.3%	$131-23.4%	$171
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	$5K-16.7%	$6K-82.5%	$34K-90.6%	$363K+60.8%	$226K-3.4%	$234K-33.4%	$351K
SG&A Expenses	$230K-4.2%	$240K+23.9%	$194K-37.0%	$307K+95.5%	$157K-33.3%	$235K-3.4%	$244K+0.9%	$242K
Operating Income	-$1.3M+9.0%	-$1.4M+15.3%	-$1.7M-49.3%	-$1.1M+10.2%	-$1.2M+2.3%	-$1.3M+23.8%	-$1.7M-11.4%	-$1.5M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$1.2M+1.3%	-$1.2M+17.4%	-$1.5M-74.1%	-$846K+33.5%	-$1.3M-29.3%	-$983K+13.6%	-$1.1M+16.0%	-$1.4M
EPS (Diluted)	$-0.28+3.4%	$-0.29+19.4%	$-0.36	N/A	$-0.42-27.3%	$-0.33+19.5%	$-0.41	N/A

MYSE Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20
Total Assets	$5.4M-17.4%	$6.5M-50.4%	$13.1M-37.0%	$20.8M+2696.5%	$744K
Current Assets	$4.3M-32.7%	$6.4M-50.5%	$12.9M-37.4%	$20.6M+2775.2%	$716K
Cash & Equivalents	$1.2M+25.5%	$953K-45.0%	$1.7M-91.4%	$20.2M+2825.7%	$690K
Inventory	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$207+13.1%	$183-52.3%	$384+38.1%	$278	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A
Total Liabilities	-$1.5M-470.8%	$407K-27.0%	$557K-23.8%	$731K+351.3%	$162K
Current Liabilities	$630K+55.0%	$407K-14.1%	$473K-18.4%	$580K+262.5%	$160K
Long-Term Debt	N/A	N/A	$84K	N/A	N/A
Total Equity	$6.9M+12.8%	$6.1M-51.4%	$12.6M-37.5%	$20.1M+3348.9%	$582K
Retained Earnings	-$52.4M-8.8%	-$48.1M-21.2%	-$39.7M-44.0%	-$27.6M-64.6%	-$16.8M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$6.8M-9.2%	$7.4M-12.4%	$8.5M+58.4%	$5.4M+11.5%	$4.8M-11.4%	$5.4M-15.3%	$6.4M-1.3%	$6.5M
Current Assets	$5.1M-12.2%	$5.8M-19.7%	$7.2M+68.0%	$4.3M-9.9%	$4.8M-11.2%	$5.4M-15.2%	$6.3M-0.9%	$6.4M
Cash & Equivalents	$458K+12.2%	$408K-67.8%	$1.3M+5.7%	$1.2M+89.2%	$632K+7.7%	$588K+135.0%	$250K-73.8%	$953K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$224+1.8%	$220-10.9%	$247+19.3%	$207+5.6%	$196+2.1%	$192-4.0%	$200+9.3%	$183
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	-$1.6M+10.9%	-$1.8M+0.4%	-$1.8M-17.6%	-$1.5M+33.4%	-$2.3M-658.5%	$406K-9.7%	$449K+10.4%	$407K
Current Liabilities	$888K+37.8%	$644K-7.9%	$699K+11.0%	$630K+18.7%	$531K+31.0%	$406K-9.7%	$449K+10.4%	$407K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$8.3M-9.5%	$9.2M-10.4%	$10.3M+49.5%	$6.9M-2.9%	$7.1M+15.7%	$6.1M-10.6%	$6.8M+12.2%	$6.1M
Retained Earnings	-$56.3M-2.2%	-$55.1M-2.3%	-$53.8M-2.8%	-$52.4M-1.6%	-$51.5M-2.5%	-$50.3M-2.0%	-$49.3M-2.4%	-$48.1M

MYSE Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$4.4M+32.8%	-$6.5M+10.0%	-$7.3M+14.1%	-$8.5M-671.7%	-$1.1M
Capital Expenditures	N/A	$49K+11.3%	$44K-20.6%	$56K	N/A
Free Cash Flow	N/A	-$6.6M+9.9%	-$7.3M+14.2%	-$8.5M	N/A
Investing Cash Flow	$2.2M-63.7%	$6.2M+155.0%	-$11.2M-19902.4%	-$56K	N/A
Financing Cash Flow	$2.4M+701.3%	-$398K-35916.9%	$1K-100.0%	$28.0M+1533.6%	$1.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$904K+25.0%	-$1.2M+14.2%	-$1.4M-59.5%	-$881K+7.9%	-$957K+10.8%	-$1.1M+27.4%	-$1.5M-7.8%	-$1.4M
Capital Expenditures	$0	N/A	N/A	N/A	N/A	N/A	N/A	$0
Free Cash Flow	-$904K	N/A	N/A	N/A	N/A	N/A	N/A	-$1.4M
Investing Cash Flow	$944K+153.8%	$372K+112.8%	-$2.9M-400.4%	$967K+30.4%	$742K-36.9%	$1.2M+281.4%	-$648K-139.0%	$1.7M
Financing Cash Flow	$10K+141.6%	-$24K-100.5%	$4.4M+815.8%	$478K+83.9%	$260K+10.2%	$236K-83.4%	$1.4M	$0
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MYSE Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Margin	-1211216.3%+95931.2pp	-1307147.5%-1280690.7pp	-26456.8%+217380.1pp	-243836.9%	N/A
Net Margin	-972284.4%+278455.2pp	-1250739.6%-1224473.6pp	-26266.0%+217356.8pp	-243622.8%	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A
Return on Assets	-78.9%+50.3pp	-129.2%-36.6pp	-92.6%-40.5pp	-52.0%+79.6pp	-131.6%
Current Ratio	6.80-8.9	15.68-11.5	27.20-8.3	35.48+31.0	4.47
Debt-to-Equity	-0.22-0.3	0.07+0.1	0.01-0.0	0.04-0.2	0.28
FCF Margin	N/A	-978982.4%-963179.3pp	-15803.1%+175660.2pp	-191463.3%	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-390427.1%+1413198.5pp	-1803625.6%+196911.7pp	-2000537.4%-791627.6pp	-1208909.8%+788161.2pp	-1997071.0%-1157929.9pp	-839141.1%+430644.4pp	-1269785.5%-396917.7pp	-872867.8%
Net Margin	-366304.0%+1193788.4pp	-1560092.3%+214842.6pp	-1774934.9%-855043.6pp	-919891.3%+1131400.6pp	-2051291.9%-1400135.0pp	-651156.9%+217401.8pp	-868558.8%-76777.5pp	-791781.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-17.8%-1.4pp	-16.3%+1.0pp	-17.3%-1.6pp	-15.8%+10.7pp	-26.4%-8.3pp	-18.1%-0.4pp	-17.7%+3.1pp	-20.8%
Current Ratio	5.72-3.3	8.98-1.3	10.30+3.5	6.80-2.2	8.96-4.2	13.20-0.9	14.07-1.6	15.68
Debt-to-Equity	-0.190.0	-0.19-0.0	-0.17+0.0	-0.22+0.1	-0.32-0.4	0.070.0	0.070.0	0.07
FCF Margin	-275748.8%	N/A	N/A	N/A	N/A	N/A	N/A	-801033.3%

Frequently Asked Questions

What is Myseum's annual revenue?

Myseum (MYSE) reported $436 in total revenue for fiscal year 2024. This represents a -35.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Myseum's revenue growing?

Myseum (MYSE) revenue declined by 35.1% year-over-year, from $672 to $436 in fiscal year 2024.

Is Myseum profitable?

No, Myseum (MYSE) reported a net income of -$4.2M in fiscal year 2024, with a net profit margin of -972284.4%.

What is Myseum's earnings per share (EPS)?

Myseum (MYSE) reported diluted earnings per share of $-1.43 for fiscal year 2024. This represents a 65.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Myseum's EBITDA?

Myseum (MYSE) had EBITDA of -$5.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Myseum's operating margin?

Myseum (MYSE) had an operating margin of -1211216.3% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Myseum's net profit margin?

Myseum (MYSE) had a net profit margin of -972284.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Myseum's operating cash flow?

Myseum (MYSE) generated -$4.4M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Myseum's total assets?

Myseum (MYSE) had $5.4M in total assets as of fiscal year 2024, including both current and long-term assets.

How much does Myseum spend on research and development?

Myseum (MYSE) invested $858K in research and development during fiscal year 2024.

How many shares does Myseum have outstanding?

Myseum (MYSE) had 3M shares outstanding as of fiscal year 2024.

What is Myseum's current ratio?

Myseum (MYSE) had a current ratio of 6.80 as of fiscal year 2024, which is generally considered healthy.

What is Myseum's debt-to-equity ratio?

Myseum (MYSE) had a debt-to-equity ratio of -0.22 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Myseum's return on assets (ROA)?

Myseum (MYSE) had a return on assets of -78.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Myseum's cash runway?

Based on fiscal year 2024 data, Myseum (MYSE) had $1.2M in cash against an annual operating cash burn of $4.4M. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Myseum's Piotroski F-Score?

Myseum (MYSE) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Myseum's earnings high quality?

Myseum (MYSE) has an earnings quality ratio of 1.04x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.